Open access · CC-BY
via OpenAlex
The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
Georgia Minakaki, Dimitri Krainc, Lena F. Burbulla
Frontiers in Cell and Developmental Biology · 2020 · ▲ 83 citations
Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease, characterized by progressive bradykinesia, rigidity, resting tremor, and gait impairment, as well as a spectrum of non-motor symptoms including autonomic and cognitive dysfunction. The cardinal motor symptoms of PD stem from the loss of substantia nigra (SN) dopaminergic (DAergic) neurons, and it remains unclear why SN DAergic neurons are preferentially lost in PD. However, recent identification of several genetic PD forms suggests that mitochondrial and lysosomal dysfunctions play important roles in the degeneration of midbrain dopamine (DA) neurons. In this review, we discuss the interplay of cell-autonomous mechanisms linked to DAergic neuron vulnerability and alpha-synuclein homeostasis. Emerging studies highlight a deleterious feedback cycle, with oxidative stress, altered DA metabolism, dysfunctional lysosomes, and pathological alpha-synuclein species representing key events in the pathogenesis of PD. We also discuss the interactions of alpha-synuclein with toxic DA metabolites, as well as the biochemical links between intracellular iron, calcium, and alpha-synuclein accumulation. We suggest that targeting multiple pathways, rather than individual processes, will be important for developing disease-modifying therapies. In this context, we focus on current translational efforts specifically targeting lysosomal function, as well as oxidative stress via calcium and iron modulation. These efforts could have therapeutic benefits for the broader population of sporadic PD and related synucleinopathies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fcell.2020.580634
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Minakaki, G., Krainc, D., & Burbulla, L.F. (2020). The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease. <em>Frontiers in Cell and Developmental Biology</em>. https://doi.org/10.3389/fcell.2020.580634
Vancouver
Minakaki G, Krainc D, Burbulla LF. The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease. Frontiers in Cell and Developmental Biology. 2020. doi:10.3389/fcell.2020.580634.
BibTeX
@article{georgia2020TheCon,
title = {The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease},
author = {Georgia Minakaki and Dimitri Krainc and Lena F. Burbulla},
journal = {Frontiers in Cell and Developmental Biology},
year = {2020},
doi = {10.3389/fcell.2020.580634},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurobiology of Disease 2022
Open access · CC-BY
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
Journal of Parkinson s Disease 2013
Open access · OA
The Role of Oxidative Stress in Parkinson's Disease
Journal of Alzheimer s Disease 2017
Open access · OA
Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Aging and Disease 2016
Open access · CC-BY
Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
Frontiers in Molecular Neuroscience 2017
Open access · CC-BY
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
Frontiers in Synaptic Neuroscience 2026
Open access · CC-BY